Commission Regulation (EC) No 1231/2006 of 16 August 2006 amending Annexes I and II to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin, as regards ceftiofur and polyoxyethylene sorbitan monooleate and trioleate   (Text with EEA relevance)
Date: 2006-08-16
Institutions: European Commission
Subjects: animal product, chemical product, foodstuff, foodstuffs legislation, material of animal origin, veterinary drug, veterinary legislation

17.8.2006

EN

Official Journal of the European Union

L 225/3

COMMISSION REGULATION (EC) No 1231/2006

of 16 August 2006

amending Annexes I and II to Council Regulation (EEC) No 2377/90 laying down a Community
procedure for the establishment of maximum residue limits of veterinary medicinal products in
foodstuffs of animal origin, as regards ceftiofur and polyoxyethylene sorbitan monooleate and
trioleate

(Text with EEA relevance)

THE COMMISSION OF THE EUROPEAN COMMUNITIES,

Having regard to the Treaty
Community,

establishing the European

Having regard to Council Regulation (EEC) No 2377/90 of 26
June 1990 laying down a Community procedure for the estab-
lishment of maximum residue limits of veterinary medicinal
products in foodstuffs of animal origin (1), and in particular
Articles 2 and 3 thereof,

Having regard to the opinions of
the European Medicines
Agency formulated by the Committee for Medicinal Products
for Veterinary Use,

Whereas:

(1)

(2)

(3)

All pharmacologically active substances used in the
Community in veterinary medicinal products intended
for
should be evaluated in
accordance with Regulation (EEC) No 2377/90.

food-producing animals

The substance Ceftiofur is currently included in Annex I
to Regulation (EEC) No 2377/90 for bovine and porcine
for muscle, fat, liver and kidney and for bovine for milk.
The entry for Ceftiofur in that Annex should be modified
to include ovine and extended to all mammalian food-
producing species for muscle, fat, liver, kidney and milk.

The substance polyoxyethylene sorbitan monooleate is
currently included in Annex II to Regulation (EEC) No
2377/90 for all food-producing species. The entry in that
Annex for polyoxyethylene sorbitan monooleate should
be replaced by polyoxyethylene sorbitan monooleate and

trioleate covering polyoxyethylene sorbitan trioleate for
all food-producing species.

Regulation (EEC) No 2377/90 should therefore be
amended accordingly.

An adequate period should be allowed before the applic-
ability of this Regulation in order to enable Member
States to make any adjustment which may be necessary
in the light of this Regulation to the authorisations to
place the veterinary medicinal products concerned on the
market which have been granted in accordance with
Directive 2001/82/EC of the European Parliament and
the Council of 6 November 2001 on the
of
Community
to veterinary medicinal
products (2) to take account of the provisions of this
Regulation.

relating

code

The measures provided for in this Regulation are in
accordance with
Standing
the
the
Committee on Veterinary Medicinal Products,

opinion

of

(4)

(5)

(6)

HAS ADOPTED THIS REGULATION:

Article 1

Annexes I and II to Regulation (EEC) No 2377/90 are amended
in accordance with the Annex to this Regulation.

Article 2

This Regulation shall enter into force on the third day following
its publication in the Official Journal of the European Union.

It shall apply from 16 October 2006.

This Regulation shall be binding in its entirety and directly applicable in all Member States.

Done at Brussels, 16 August 2006.

For the Commission

Günter VERHEUGEN
Vice-President

(1) OJ L 224, 18.8.1990, p. 1. Regulation as

(EC) No 1055/2006 (OJ

last amended by
L 192,

Commission Regulation
13.7.2006, p. 3).

(2) OJ L 311, 28.11.2001, p. 1. Directive as last amended by Directive

2004/28/EC (OJ L 136, 30.4.2004, p. 58).

L 225/4

EN

Official Journal of the European Union

17.8.2006

s
e
u
s
s
i
t

t
e
g
r
a
T

s
L
R
M

s
e
i
c
e
p
s

l
a
m
n
A

i

e
u
d
i
s
e
r

r
e
k
r
a
M

)
s
(
e
c
n
a
t
s
b
u
s

e
v
i
t
c
a

l

y
l
l
a
c
i
g
o
o
c
a
m
r
a
h
P

s
n
i
r
o
p
s
o
l
a
h
p
e
C

.

e
l
c
s
u
M

)
1
(

t
a
F

r
e
v
i
L

y
e
n
d
K

i

k

l
i

M

g
k
/
g

g
k
/
g

g
k
/
g

g
k
/
g

g
k
/
g

μ

μ

μ

μ

μ

0
0
0
1

0
0
0
2

0
0
0
2

0
0
0
6

0
0
1

s
e
i
c
e
p
s

g
n
i
c
u
d
o
r
p
-
d
o
o
f

n
a
i
l
a
m
m
a
m

l
l

A

m
a
t
c
a
l
a
t
e
b

e
h
t

i

g
n
n
i
a
t
e
r

s
e
u
d
i
s
e
r

l
l
a

f
o

m
u
S

r
u
f
o
i
t
f
e
c
l
y
o
r
u
f
s
e
d

s
a

d
e
s
s
e
r
p
x
e

e
r
u
t
c
u
r
t
s

r
u
f
o
i
t
f
e
C

‘

.

2
2
1

.

X
E
N
N
A

:
)
d
e
x
i
f

n
e
e
b

e
v
a
h

s
t
i

m

i
l

e
u
d
i
s
e
r

m
u
m
i
x
a
m

h
c
i
h
w

r
o
f

s
e
c
n
a
t
s
b
u
s

e
v
i
t
c
a

l

y
l
l
a
c
i
g
o
o
c
a
m
r
a
h
p

f
o

t
s
i
L
(

0
9
/
7
7
3
2

o
N

)

C
E
E
(

n
o
i
t
a
l
u
g
e
R

o
t

I

x
e
n
n
A

n

i

d
e
t
r
e
s
n

i

s
i

e
c
n
a
t
s
b
u
s

i

g
n
w
o

l
l

o
f

e
h
T

.

A

s
t
n
e
g
a

s
u
o
i
t
c
e
f
n
i
-
i
t
n
A

.

1

i

s
c
i
t
o
b
i
t
n
A

.

2
1

.

s
e
i
c
e
p
s

l
a
m
n
A

i

)
s
(
e
c
n
a
t
s
b
u
s

e
v
i
t
c
a

l

y
l
l
a
c
i
g
o
o
c
a
m
r
a
h
P

’

s
e
i
c
e
p
s

g
n
i
c
u
d
o
r
p
-
d
o
o
f

l
l

A

e
t
a
e
l
o
i
r
t

d
n
a

e
t
a
e
l
o
o
n
o
m
n
a
t
i
b
r
o
s

e
n
e
l
y
h
t
e
y
x
o
y
o
P

l

‘

:
)
s
t
i

m

i
l

e
u
d
i
s
e
r

m
u
m
i
x
a
m

o
t

t
c
e
j
b
u
s

t
o
n

s
e
c
n
a
t
s
b
u
s

f
o

t
s
i
L
(

0
9
/
7
7
3
2

o
N

)

C
E
E
(

n
o
i
t
a
l
u
g
e
R

o
t

I
I

x
e
n
n
A

n

i

d
e
t
r
e
s
n

i

s
i

e
c
n
a
t
s
b
u
s

i

g
n
w
o

l
l

o
f

e
h
T

.

B

e
f
a
s

s
a

d
e
s
i
n
g
o
c
e
r

y
l
l
a
r
e
n
e
g

s
e
c
n
a
t
s
b
u
S

.

3

’

.

”

s
n
o
i
t
r
o
p
o
r
p

l
a
r
u
t
a
n

n

i

t
a
f

d
n
a

i

n
k
s

“

o
t

s
e
t
a
l
e
r

L
R
M

s
i
h
t

s
e
i
c
e
p
s

e
n
i
c
r
o
p

r
o
F

)
1
(